Evidence map›Paper›PMID 40245428›Full record

ArticleJMIR mHealth and uHealth2025

Trustworthiness of Web-Based Pharmacy Apps in Pakistan Based on the Mobile App Rating Scale: Content Analysis and Quality Evaluation.

Anum Sattar, Hina Rehman, Safila Naveed, Sumaira Khadim, Nargis Khan, Ahmad Furqan Kazi, Wajid Syed, Mahmood Basil A Al-Rawi, Shazia Jamshed

Erratum issuedAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Anum Sattar *Department of Pharmacy Practice, Jinnah University for Women, 5C, Block 5 Nazimabad, Karachi, 74600, Pakistan, 92 3443786840.ORCID 0000-0002-5856-674X
Hina Rehman *Department of Pharmacy Practice, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan.ORCID 0009-0000-8066-1156
Safila Naveed *Department of Pharmaceutical Chemistry, University of Karachi, Karachi, Pakistan.ORCID 0000-0002-8105-9180
Sumaira Khadim *Department of Pharmacy Practice, Faculty of Pharmacy, Iqra University, Karachi, Pakistan.ORCID 0009-0001-2201-0643
Nargis Khan *Department of General Medicine, Dow University of Health Sciences, Karachi, Pakistan.ORCID 0009-0002-6288-027X
Ahmad Furqan KaziDepartment of Pharmacy Practice, College of Pharmacy, Purdue University in Indianapolis, Indianapolis, United States.ORCID 0000-0001-9805-7213
Wajid SyedDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-4077-4524
Mahmood Basil A Al-RawiDepartment of Optometry College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-1056-8623
Shazia Jamshed *Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.ORCID 0000-0003-0773-0463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Web-based pharmacy apps facilitate the electronic exchange of health-related supplies. They are digital platforms that run on websites and smartphones. Pakistan is experiencing significant progress in smartphone integration and digital services, leading to the expansion of the online pharmacy business. However, concerns remain over the legitimacy and precision of these apps. Objective: The aim of this study was to undertake a thorough assessment of digital pharmacy apps accessible in Pakistan. Specifically, our focus was on apps accessible via the Google Play Store and the iOS App Store. To fulfill this objective, an evaluation of these apps was performed using the Mobile App Rating Scale (MARS). Methods: A research investigation was conducted to analyze the online pharmacy apps in Pakistan. Initially, 50 apps were identified, but 10 were excluded for not meeting pre-established criteria, 10 were excluded for being in languages other than English, and 7 could not be downloaded. All paid and non-English apps were also excluded. A total of 23 apps were selected for the study, acquired via the Google Play Store and iOS App Store. The evaluation was conducted by 2 researchers who maintained independence from one another by using the MARS. Results: Initially, 50 apps were identified, of which 27 were excluded for not meeting the predetermined criteria. A total of 23 apps were selected for the study, acquired via the Google Play Store and iOS App Store. Strong positive correlations between higher user engagement and better app functionality and information quality were observed. The average rating of the 23 apps ranged between 2.64 and 4.00 on a scale up to 5. The aesthetics dimension had the highest mean score of 3.6, while the information dimension had the lowest mean score of 3.2. For credibility and reliability, different tests (intraclass correlation, Cohen κ, Krippendorff α, and Cronbach α) on each dimension of the MARS were performed by using SPSS Statistics 27. The intraclass correlation of all MARS dimensions ranged from 0.702-0.913 (95% CI 0.521-0.943), the Cohen κ of all MARS dimensions ranged from 0.388-0.907 (95% CI 0.151-0.994), the Krippendorff α of all MARS dimensions ranged from 0.705-0.979 (95% CI 0.657-0.923), and Cronbach α had a lower score of 0.821 in the information dimension and a higher score of .911 in the subjective quality dimension of the MARS. Conclusions: This study evaluated online pharmacy apps in Pakistan by using the MARS. It is the first study on online pharmacy apps in Pakistan. The findings of the evaluation have provided insights into the reliability and efficacy of these apps.

Indexed as

Mobile ApplicationsHumansInternetPakistanappsdigital platformsefficacyengagementfunctionalityMARSmobile appMobile App Rating Scaleonline pharmacyonline pharmacy appsPakistanpharmacyquestionnairesmartphone apptrustworthinessuser

Identifiers

PMID40245428
PMCPMC12021373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.